Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Holding JP:2395?
Track your performance easily
2395 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥970.00 - ¥1,838.00
Previous CloseN/A
Volume203.40K
Average Volume (3M)N/A
Market Cap
¥67.94B
Enterprise Value¥72.45B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)17.4
Beta0.95
Next Earnings
Feb 05, 2025EPS EstimateN/A
Next Dividend Ex-Date
Mar 28, 2025Dividend Yield3.06%
Share Statistics
EPS (TTM)93.58
Shares Outstanding41,632,400
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,460.00Price Target Upside-11.03% Downside
Rating ConsensusHold
Number of Analyst Covering1
Shin Nippon Biomedical Laboratories, Ltd. News
PremiumCompany Announcements
SNBL Partners with Mizuho Bank for Eco Finance
PremiumCompany Announcements
Shin Nippon’s Dr. Nagata Awarded Bhutan’s Top Honor
PremiumCompany Announcements
SNBL’s Satsuma Pharma Achieves FDA Milestone
PremiumCompany Announcements
Shin Nippon Biomedical Laboratories Focuses on Governance and Growth
PremiumCompany Announcements
SNBL Strengthens Korean Market Presence with WOOJUNG BIO Investment
PremiumCompany Announcements
SNBL Partners with Plug and Play to Boost Start-Up GrowthPremiumCompany Announcements
Shin Nippon Biomedical Exceeds Financial Forecasts for 2024
PremiumCompany Announcements
Shin Nippon Biomedical Labs Declares Interim DividendsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.56% Mutual Funds
― Other Institutional Investors
96.26% Public Companies and
Individual Investors
2395 FAQ
What was Shin Nippon Biomedical Laboratories, Ltd.’s price range in the past 12 months?
Shin Nippon Biomedical Laboratories, Ltd. lowest stock price was ¥970.00 and its highest was ¥1838.00 in the past 12 months.
What is Shin Nippon Biomedical Laboratories, Ltd.’s market cap?
Shin Nippon Biomedical Laboratories, Ltd.’s market cap is ¥67.94B.
When is Shin Nippon Biomedical Laboratories, Ltd.’s upcoming earnings report date?
Shin Nippon Biomedical Laboratories, Ltd.’s upcoming earnings report date is Feb 05, 2025 which is in 17 days.
How were Shin Nippon Biomedical Laboratories, Ltd.’s earnings last quarter?
Shin Nippon Biomedical Laboratories, Ltd. released its earnings results on Nov 06, 2024. The company reported ¥29.04 earnings per share for the quarter, beating the consensus estimate of ¥26.892 by ¥2.148.
Is Shin Nippon Biomedical Laboratories, Ltd. overvalued?
According to Wall Street analysts Shin Nippon Biomedical Laboratories, Ltd.’s price is currently Overvalued.
Does Shin Nippon Biomedical Laboratories, Ltd. pay dividends?
Shin Nippon Biomedical Laboratories, Ltd. pays a N/A dividend of ¥50 which represents an annual dividend yield of 3.06%. See more information on Shin Nippon Biomedical Laboratories, Ltd. dividends here
What is Shin Nippon Biomedical Laboratories, Ltd.’s EPS estimate?
Shin Nippon Biomedical Laboratories, Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shin Nippon Biomedical Laboratories, Ltd. have?
Shin Nippon Biomedical Laboratories, Ltd. has 41,632,400 shares outstanding.
What happened to Shin Nippon Biomedical Laboratories, Ltd.’s price movement after its last earnings report?
Shin Nippon Biomedical Laboratories, Ltd. reported an EPS of ¥29.04 in its last earnings report, beating expectations of ¥26.892. Following the earnings report the stock price went up 8.622%.
Which hedge fund is a major shareholder of Shin Nippon Biomedical Laboratories, Ltd.?
Currently, no hedge funds are holding shares in JP:2395
---
Technical Analysis
Daiichi Sankyo Company
―
Astellas Pharma
―
Eisai Co
―
Takeda Pharmaceutical Co
―
Chugai Pharmaceutical Co
―
---